Evaluating the performance of egami, kobayashi and sano scores in predicting IVIG resistance in infant kawasaki disease

• Published in: BMC pediatrics Vol. 24; no. 1; pp. 606 - 8
• Main Authors: Lim, Young Tae, Kwon, Jung Eun, Kim, Yeo Hyang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 28.09.2024; BioMed Central; BMC
• Subjects: Bilirubin; Children; Comparative analysis; Diseases; Drug Resistance; Drug therapy; Egami score; Female; Humans; Immunoglobulins, Intravenous - therapeutic use; Immunologic Factors - therapeutic use; Infant; Infants; Intravenous immunoglobulin; IVIG resistance; Kawasaki disease; Male; Medical research; Medicine, Experimental; Mucocutaneous Lymph Node Syndrome - drug therapy; Pediatric research; Physiological aspects; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk scores; ROC Curve; Sensitivity and Specificity; South Korea; Japan; Taiwan; Kobayashi score; Sano score; Kawasaki disease; Egami score; Intravenous immunoglobulin; Infants; Risk scores; IVIG resistance
• ISSN: 1471-2431; 1471-2431
• DOI: 10.1186/s12887-024-05035-z

This study aimed to evaluate the effectiveness of Egami, Kobayashi and Sano scores in predicting intravenous immunoglobulin (IVIG) resistance in infant Kawasaki disease (KD), considering its unique clinical presentation. We retrospectively analysed 143 infants aged < 12 months and diagnosed with KD at a single centre from 2019 to 2023. Patients were divided into IVIG-resistant and IVIG-responsive groups. Demographic, clinical and laboratory data were compared between the groups. The diagnostic performance of Egami, Kobayashi and Sano scores in predicting IVIG resistance was evaluated using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and area under the receiver operating characteristic curve (AUC). Additionally, we developed a new scoring system based on significant predictors identified in our cohort. Among 143 infants, 45 (31.5%) showed IVIG resistance. The IVIG-resistant group had a significantly higher rate of coronary artery lesions (15.6% vs. 5.1%, p = 0.036). Incomplete KD was observed in 61.5% of cases. Egami, Kobayashi and Sano scores exhibited low sensitivity (35.6%, 55.6% and 20%, respectively) and moderate specificity (77.6%, 63.3% and 95.9%, respectively) in predicting IVIG resistance. The AUC ranged from 0.583 to 0.674, indicating poor to fair discriminative ability. Our newly developed scoring system, based on total bilirubin and albumin levels, showed similar performance (AUC 0.633) to existing scores. Existing Japanese risk scoring systems and our newly developed score showed limited effectiveness in predicting IVIG resistance in infant KD. The high proportion of incomplete presentation and IVIG resistance in infants highlights the need for age-specific risk assessment and management. Further research is necessary to develop more sophisticated, dedicated prediction model for IVIG resistance in infants with KD.